Filter
144
Text search:
genotypic
testing
Featured
29
40
Language
Document type
66
38
24
8
4
1
1
1
Countries
6
4
4
4
4
4
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
34
26
8
7
1
1
1
Toolboxes
53
16
14
9
8
3
3
3
2
2
2
2
1
1
1
1
1
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen
...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
mBio, Vol. 6 Issue 2, March/April 2015
Available evidence demonstrates that direct patient contact and contact with infectious body fluids are the primary modes for Ebola virus transmission, but this is based on a limited number of studies. In this review, the authors address what we know and what
...
The guideline elaborates on the prevention and control strategy developed by the South-East Asia Regional Office of WHO, which consists of six key components.
Antimicrobial resistance (AMR) is a major global public health concern and a food safety issue. When pathogens become resistant to antimicrobial agents they can pose a greater human health risk as a result of potential treatment failure, loss of treatment options and increased likelihood and severi
...
2nd edition
2nd edition. WHO's recommendation has not changed: the standard WHO susceptibility tests should remain a primary method by which resistance is detected. However, it was considered necessary to update the existing resistance-monitoring procedures to also highlight the need for operationally meaningfu
...
3rd edition
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Lancet Planet Health 2017 Published Online November 6, 2017 http://dx.doi.org/10.1016/S2542-5196(17)30141-9
Antimicrobial Resistance and Infection Control 2014,3 :31
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three
...
